10x Genomics (TXG) Short Interest Ratio & Short Volume

10x Genomics logo
$12.31 +0.37 (+3.10%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$12.56 +0.25 (+2.03%)
As of 02/14/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

10x Genomics Short Interest Data

10x Genomics (TXG) has a short interest of 8.42 million shares. This marks a 10.64% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.0, indicating that it would take 4.0 days of the average trading volume of 1.98 million shares to cover all short positions.

Current Short Interest
8,420,000 shares
Previous Short Interest
7,610,000 shares
Change Vs. Previous Month
+10.64%
Dollar Volume Sold Short
$126.30 million
Short Interest Ratio
4.0 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
121,054,000 shares
Percentage of Shares Shorted
6.96%
Today's Trading Volume
4,354,670 shares
Average Trading Volume
1,977,831 shares
Today's Volume Vs. Average
220%
Short Selling 10x Genomics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for 10x Genomics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TXG Short Interest Over Time

TXG Days to Cover Over Time

TXG Percentage of Float Shorted Over Time

10x Genomics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20258,420,000 shares $126.30 million +10.6%N/A4 $15.00
1/15/20257,610,000 shares $114.00 million +15.3%N/A4 $14.98
12/31/20246,600,000 shares $94.78 million +7.0%N/A3.1 $14.36
12/15/20246,170,000 shares $87.64 million -10.6%N/A3 $14.21
11/30/20246,900,000 shares $109.71 million +0.6%N/A3.5 $15.90
11/15/20246,860,000 shares $91.51 million -9.9%N/A3.5 $13.34
10/31/20247,610,000 shares $121.99 million -0.5%N/A4.1 $16.03
10/15/20247,650,000 shares $121.71 million +2.8%N/A4.3 $15.91
9/30/20247,440,000 shares $168.00 million -4.7%N/A4.2 $22.58
9/15/20247,810,000 shares $174.71 million -12.6%N/A4.2 $22.37
8/31/20248,940,000 shares $208.75 million -14.2%N/A4.9 $23.35
8/15/202410,420,000 shares $235.91 million -6.3%N/A5.8 $22.64
7/31/202411,120,000 shares $229.85 million +8.9%N/A6.1 $20.67
7/15/202410,210,000 shares $176.84 million -4.4%N/A5.4 $17.32
6/30/202410,680,000 shares $207.73 million +1.9%N/A6.2 $19.45
6/15/202410,480,000 shares $212.22 million +5.7%N/A6.7 $20.25
5/31/20249,920,000 shares $222.41 million -2.1%N/A6.2 $22.42
5/15/202410,130,000 shares $267.33 million -1.3%N/A6.3 $26.39
4/30/202410,260,000 shares $300.41 million +15.7%N/A6.4 $29.28
4/15/20248,870,000 shares $291.47 million +4.1%N/A6.3 $32.86
3/31/20248,520,000 shares $319.76 million -0.7%N/A6.1 $37.53
3/15/20248,580,000 shares $311.71 million +24.5%N/A6.3 $36.33
2/29/20246,890,000 shares $321.35 million +7.3%N/A5.2 $46.64
2/15/20246,420,000 shares $308.61 million -3.6%N/A5.2 $48.07
1/31/20246,660,000 shares $277.52 million +16.4%N/A5.7 $41.67
1/15/20245,720,000 shares $268.78 million +22.8%N/A4.8 $46.99
12/31/20234,660,000 shares $260.77 million -15.4%N/A4.5 $55.96
12/15/20235,510,000 shares $294.62 million +6.2%N/A5.7 $53.47
11/30/20235,190,000 shares $225.87 million -8.6%N/A5.4 $43.52
11/15/20235,680,000 shares $229.53 million -15.7%N/A5.8 $40.41
10/31/20236,740,000 shares $237.79 million +0.6%N/A7 $35.28
10/15/20236,700,000 shares $258.02 million +16.7%N/A7.2 $38.51
9/30/20235,740,000 shares $236.78 million +13.7%N/A6.1 $41.25
9/15/20235,050,000 shares $251.14 million +5.7%N/A5.4 $49.73
8/31/20234,780,000 shares $247.84 million -1.0%N/A5.2 $51.85
8/15/20234,830,000 shares $235.37 million +1.5%N/A5.1 $48.73
7/31/20234,760,000 shares $299.78 million -5.6%N/A5 $62.98
7/15/20235,040,000 shares $292.82 million -5.6%5.9%5.4 $58.10
6/30/20235,340,000 shares $298.19 million +3.5%6.3%5.9 $55.84
6/15/20235,160,000 shares $303.00 million -3.9%6.1%5.7 $58.72
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
5/31/20235,370,000 shares $281.71 million -2.2%6.3%5.9 $52.46
5/15/20235,490,000 shares $295.42 million -8.0%N/A6.2 $53.81
4/30/20235,970,000 shares $313.01 million -6.6%N/A6.5 $52.43
4/15/20236,390,000 shares $345.25 million -3.2%N/A7.1 $54.03
3/31/20236,600,000 shares $368.21 million +2.5%N/A6.5 $55.79
3/15/20236,440,000 shares $312.86 million +4.4%N/A6.2 $48.58
2/28/20236,170,000 shares $293.20 million +5.8%N/A5.5 $47.52
2/15/20235,830,000 shares $269.75 million -4.6%N/A5.1 $46.27
1/31/20236,110,000 shares $286.13 million -1.5%7.1%5 $46.83
1/15/20236,200,000 shares $267.96 million -16.9%7.2%4.6 $43.22
12/30/20227,460,000 shares $271.84 million -13.5%8.7%5.7 $36.44
12/15/20228,620,000 shares $308.42 million -3.3%10.1%6.7 $35.78
11/30/20228,910,000 shares $344.46 million +4.2%10.4%7 $38.66
11/15/20228,550,000 shares $346.28 million +50.3%10.0%6.9 $40.50
10/31/20225,690,000 shares $154.65 million +15.7%6.7%4.6 $27.18
10/15/20224,920,000 shares $125.85 million -6.8%5.8%4.3 $25.58
9/30/20225,280,000 shares $150.37 million +1.3%6.2%4 $28.48
9/15/20225,210,000 shares $174.48 million +9.9%6.1%3.7 $33.49
8/31/20224,740,000 shares $156.37 million -0.4%5.6%3.3 $32.99
8/15/20224,760,000 shares $226.48 million +5.5%5.6%3.1 $47.58
7/31/20224,510,000 shares $181.08 million -24.5%5.3%2.6 $40.15
7/15/20225,970,000 shares $214.32 million -2.0%7.1%3.3 $35.90
6/30/20226,090,000 shares $275.57 million -11.6%7.2%3.9 $45.25
6/15/20226,890,000 shares $272.98 million +1.9%8.2%4.4 $39.62
5/31/20226,760,000 shares $346.04 million -4.9%8.0%4.6 $51.19
5/15/20227,110,000 shares $338.65 million +30.7%8.4%5.1 $47.63
4/30/20225,440,000 shares $259.81 million +1.3%6.5%3.9 $47.76
4/15/20225,370,000 shares $348.41 million +7.0%6.4%4.3 $64.88
3/31/20225,020,000 shares $381.87 million +15.7%6.0%3.9 $76.07
3/15/20224,340,000 shares $243.91 million +4.8%5.2%3.6 $56.20
2/28/20224,140,000 shares $337.29 million -0.2%4.9%3.7 $81.47
2/15/20224,150,000 shares $395.50 million -0.2%4.9%3.5 $95.30
1/31/20224,160,000 shares $400.48 million +23.1%5.1%4.6 $96.27
1/15/20223,380,000 shares $351.52 million +10.1%4.1%4.1 $104.00
12/31/20213,070,000 shares $457.31 million -7.8%3.7%4.6 $148.96
12/15/20213,330,000 shares $467.63 million No Change4.0%4.9 $140.43
11/30/20213,330,000 shares $508.86 million +1.8%4.0%4.6 $152.81
11/15/20213,270,000 shares $516.66 million -12.6%4.0%5.3 $158.00
10/29/20213,740,000 shares $603.15 million -2.4%4.6%6.2 $161.27
10/15/20213,830,000 shares $583.19 million +12.7%4.7%6.3 $152.27
9/30/20213,400,000 shares $494.97 million -2.0%4.2%5.6 $145.58
9/15/20213,470,000 shares $541.84 million +11.2%4.3%5.5 $156.15
8/31/20213,120,000 shares $548.87 million +12.6%3.9%4.8 $175.92
8/13/20212,770,000 shares $443.98 million -2.8%3.4%3.9 $160.28
7/30/20212,850,000 shares $522.21 million -3.4%3.8%3.6 $183.23
7/15/20212,950,000 shares $501.65 million -4.8%3.9%3.5 $170.05
6/30/20213,100,000 shares $607.04 million +2.3%4.1%3.6 $195.82
6/15/20213,030,000 shares $576.28 million +25.2%4.0%3.6 $190.19
5/28/20212,420,000 shares $435.60 million +12.6%3.2%3 $180.00
5/14/20212,150,000 shares $293.71 million +55.8%2.8%2.6 $136.61
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
4/30/20211,380,000 shares $272.41 million -12.7%1.9%1.8 $197.40
4/15/20211,580,000 shares $303.71 million -11.2%2.1%2.2 $192.22
3/31/20211,780,000 shares $299.43 million +48.3%2.4%2.3 $168.22
3/15/20211,200,000 shares $192.02 million +20.5%1.7%1.5 $160.02
2/26/2021996,200 shares $172.44 million -5.1%1.4%1.3 $173.10
2/12/20211,050,000 shares $199.63 million +11.6%1.6%1.3 $190.12
1/29/2021941,200 shares $163.13 million -13.7%1.7%1.2 $173.32
1/15/20211,090,000 shares $196.08 million +13.5%1.8%1.4 $179.89
12/31/2020960,800 shares $137.02 million -12.7%1.6%1.2 $142.61
12/15/20201,100,000 shares $166.93 million +14.4%1.8%1.4 $151.75
11/30/2020961,200 shares $144.82 million +12.0%1.5%1.1 $150.67
11/15/2020858,300 shares $118.92 million -20.5%1.4%1.1 $138.55
10/30/20201,080,000 shares $152.00 million -27.5%1.7%1.4 $140.74
10/15/20201,490,000 shares $240.59 million -20.7%2.3%1.9 $161.47

TXG Short Interest - Frequently Asked Questions

What is 10x Genomics' current short interest?

Short interest is the volume of 10x Genomics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 8,420,000 shares of TXG short. Learn More on 10x Genomics' current short interest.

What is a good short interest ratio for 10x Genomics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TXG shares currently have a short interest ratio of 4.0. Learn More on 10x Genomics's short interest ratio.

Which institutional investors are shorting 10x Genomics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 10x Genomics: Group One Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is 10x Genomics' short interest increasing or decreasing?

10x Genomics saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 8,420,000 shares, an increase of 10.6% from the previous total of 7,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does 10x Genomics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "measuring and control equipment" compare to 10x Genomics: Vontier Co. (1.74%), Camtek Ltd. (14.41%), Sensata Technologies Holding plc (2.71%), Mirion Technologies, Inc. (1.84%), Transcat, Inc. (3.85%), Cytek Biosciences, Inc. (2.72%), Standard BioTools Inc. (3.56%), EyePoint Pharmaceuticals, Inc. (15.71%), Allient Inc. (1.25%), Aehr Test Systems (22.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short 10x Genomics stock?

Short selling TXG is an investing strategy that aims to generate trading profit from 10x Genomics as its price is falling. TXG shares are trading up $0.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 10x Genomics?

A short squeeze for 10x Genomics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TXG, which in turn drives the price of the stock up even further.

How often is 10x Genomics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXG, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:TXG) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners